Skip to Main

Search

Results 361 to 370 of 1,049 for ""

Diabetes drug metformin may protect against radiation exposure: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2024/aug-diabetes-drug-metformin.html

Metformin, a well-tolerated diabetes drug prescribed to as many as 150 million people worldwide, may also protect cells from radioactive damage, UT Southwestern Medical Center researchers report.

UTSW physician named 2022 National Academy of Medicine Scholar in Diagnostic Excellence: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2022/july-nam-scholar.html

Reuben Arasaratnam, M.D., M.P.H., Assistant Professor of Internal Medicine at UT Southwestern, has been named one of 11 2022 Scholars in Diagnostic Excellence by the National Academy of Medicine (NAM).

Blood vessel cells implicated in chronic inflammation of obesity: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2020/blood-vessel-cells-obesity.html

Low-level inflammation is one of the driving factors behind many of the diseases associated with obesity.

UT Southwestern researchers identify risk factors for unsuccessful bunion surgery: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2023/january-unsuccessful-bunion-surgery.html

A study by UT Southwestern researchers has identified three factors that increase the risk that bunion surgery will fail to fix this painful foot condition.

Precision editing of gut bacteria reduces cancer in mice: Newsroom - UT Southwestern, Dallas, TX

https://www.utsouthwestern.edu/newsroom/articles/year-2019/precision-editing-gut-bacteria.html

UT Southwestern researchers have shown that precision editing of the bacterial populations in the gut reduces inflammation-associated colorectal cancer in mice.

Study offers insight into management of patients who have interstitial pneumonia with autoimmune features : Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2022/july-interstitial-pneumonia.html

Interstitial pneumonia with autoimmune features (IPAF) is a disease with many possible causes and no standard of care, making it particularly difficult to treat. While immunosuppressant drugs are primarily prescribed, they don’t work for all patients.

UTSW’s Medical Student Group named Texas Medical Association Chapter of the Year : Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2022/utsw-medical-student-group.html

A student group at UT Southwestern Medical School has been named the 2022 Chapter of the Year by the Texas Medical Association Medical Student Section.

UTSW scientists identify cancer-suppressing genetic mutation: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2024/dec-cancer-suppressing-gene.html

UT Southwestern Medical Center researchers identified a genetic mutation that slows the growth of melanoma and potentially other cancers by harnessing the power of the immune system. Their findings, published in the Journal of Experimental Medicine, could lead to new treatments that improve outcomes

Experimental depression treatment preserves cognitive function: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2025/jan-experimental-depression-treatment.html

An experimental treatment for depression that triggers seizures with magnets significantly improved mental health in patients without some cognitive effects associated with electroconvulsive therapy (ECT), a clinical trial led by UT Southwestern Medical Center researchers showed.

Genetic testing moving into the mainstream, UTSW study finds: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2024/dec-genetic-testing-mainstream.html

Genetic testing, which has expanded in recent years with advances in technology and the development of consumer products, is on a path to widespread acceptance in the U.S., researchers at UT Southwestern Medical Center found.